Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of pneumocystis cariniipneumonia: A prospective, randomized, controlled clinical trial

Journal of Acquired Immune Deficiency Syndromes

Volumn 7, Issue 5, 1994, Pages 457-462

  May, Th ^a   Beuscart, C ^b   Reynes, J ^c   Marchou, B ^d   Leclercq, P ^e   Lebas, F Borsa ^a   Saba, J ^f   Micoud, M ^e   Mouton, Y ^b   Canton, Ph ^a  

^a University Hospital   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e University of Grenoble Alpes   (France)

^f BICHAT HOSPITAL   (France)

Author keywords

HIV; Pentamidine aerosols; Pneumocystis carinii pneumonia; Sulfamethoxazole; Trimethoprim

Indexed keywords

CD4 ANTIGEN; COTRIMOXAZOLE; DIDANOSINE; IMMUNOGLOBULIN G; PENTAMIDINE ISETHIONATE; SALBUTAMOL; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERAMYLASEMIA; IMMUNOBLOTTING; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RASH; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TOXOPLASMOSIS;

ADULT; AEROSOLS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TOXOPLASMOSIS, CEREBRAL; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0028345232     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Glatt AE, Chirgwin K, Landesman SH. Treatment of infections associated with human immunodeficiency virus. N Engl J Med 1984;310:1682-8.
2. Moss AR, Mc Callum G, Volberding PA, Bacchetti P, Dritz S. Mortality associated with mode of presentation in the acquired immunodeficiency syndrome. J Natl Cancer Inst 1984;73:1281-4.
3. Rainer CA, Feigal DW, Leoung G, Clement M, Wofsy CB. Prognosis and natural history of Pneumocystis carinii pneumonia: indicators for early and late survival. Proceedings of the IIIrd International Conference on AIDS, Washington, DC, June 1987. Abs THP-154.
4. Phair J, Munoz A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 1990;322:161-5.
5. Masur H, Ognibene FP, Yarchoan R, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 1989;111: 223-31.
6. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR 1989;38(suppl 5):1-9.
7. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4 positive cells per cubic millimeter. N Engl J Med 1990;322:941-9.
8. Collier AC, Bozette S, Coombs RW, et al. A pilot study of low dose zidovudine in human immunodeficiency virus infection. N Engl J Med 1990;323:1015-21.
9. Morlat P, Parneix P, Douard D, et al. Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. AIDS 1993;6:1187-93.
10. Hirschei B, Lazzarin A, Chopard P, et al. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 1991;324:1079-83.
11. Leoung GS, Feigal DW, Montgomery B, et al. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. N Engl J Med 1990;323:769-75.
12. Girard PM, Landman R, Gaudebout C, et al. Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine treated AIDS patients. Lancet 1989;i:1348-53.
13. Fischl MA, Dickinson GM. La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988; 259:1185-9.
14. Ruskin J, Lariviere M. Low dose cotrimoxazole of Pneumocystis carinii pneumonia in human immunodeficiency virus disease. Lancet 1991;337:468-71.
15. Hugues WJ, Kuhn S, Chaudary S, et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonia. N Engl J Med 1977;297:1419-26.
16. Raviglione MC, Nsah EN, Cortes H, Marivz P, Saniana V. Intermittent cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia. Lancet 1990,336:180.
17. Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonia. N Engl J Med 1987;316:1627-32.
18. Hughes WT, Kennedy W, Dugdale B, et al. Prevention of Pneumocystis carinii pneumonia in AIDS patient with weekly dapsone. Lancet 1990;336:1066.
19. Kemper CA, Tucker RM, Lang OS, et al. Low dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS related complex. AIDS 1990;4:1145-8.
20. Fischl MA, Dickinson GM. Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 1986;105:629.
21. Schneider MME, Hoepelman AI, Schattenkerk JK. A controlled trial of aerosolized pentamidine or trimethoprim sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992;327:1836-41.
22. Hardy WD, Feinberg J, Finkelstein DM, et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;327:1842-8.
23. Antinori A, Murri R, Tamburrini E, De Luca A, Ortona L. Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia. Lancet 1992;340:788.
24. Mallolas J, Zamora L, Gatell JM, et al. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine. AIDS 1993;7:59-64.
25. Girard PM, Landman R, Gaudebout C, et al. A controlled trial of dapsone-pyrimethamine versus pentamidine aerosol for primary prophylaxis of Pneumocystis carinii pneumonia and opportunistic toxoplasmosis in patients with human immunodeficiency virus infection. N Engl J Med 1993;328: 1514-20.
26. Blum RN, Miller LA, Gaggini L, Cohn DL. Comparative trial of dapsone versus trimethoprim-sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr 1992;5:341-7.